# Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites

**Authors:** Nikita Denisov, Fabian Springer, Amber Brauer-Nikonow, George Maftei, Georg Zeller, Denise Medeiros Selegato, Michael Zimmermann

PMC · DOI: 10.1007/s00216-025-06256-6 · Analytical and Bioanalytical Chemistry · 2025-12-15

## TL;DR

This paper introduces a new GC-MS/MS method to measure 120 gut microbiota metabolites, enabling better understanding of their roles in health and disease.

## Contribution

A novel GC-MS/MS method for absolute quantification of 120 gut microbiota-derived metabolites in various biological samples.

## Key findings

- The method enables quantification of metabolites in plasma, liver, feces, and intestinal content.
- It works with stool samples stored in DNA stabilization buffers used in microbiome sequencing.
- The method uses isotopically labeled internal standards for accurate absolute quantification.

## Abstract

The gut microbiota produces metabolites that are important for host physiology and have critical roles in the development of diseases, such as metabolic disorders, cardiovascular diseases, and cancer. Here, we developed a gas chromatography-coupled tandem mass spectrometry (GC-MS/MS) method for the quantification of 120 volatile and semi-volatile compounds produced by gut bacteria, including short-chain fatty acids, indols, nucleotides, organic acids, and amino acid derivatives. The method is based on multiple-reaction-monitoring (MRM) of each analyte and their respective isotopically labeled internal standard, enabling absolute metabolite quantification between 0.45 pmol and 1 nmol. Applying the method to different tissue samples from germfree and conventionally colonized mice, we illustrate the ability to quantify microbiota-produced metabolites in different sample matrices—plasma, liver, feces, and intestinal content—and at different concentrations. Lastly, we demonstrate that this protocol is capable of quantifying microbiota-derived metabolites in stool samples stored in DNA stabilization buffers that are typically used in sequencing-based microbiome studies. Altogether, the developed GC-MS/MS method adds a valuable analytical tool to quantify microbiota-host metabolic interactions.

The online version contains supplementary material available at 10.1007/s00216-025-06256-6.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), metabolic disorders (MESH:D008659), cardiovascular diseases (MESH:D002318)
- **Chemicals:** amino acid (MESH:D000596), short-chain fatty acids (MESH:D005232), indols (-), nucleotides (MESH:D009711)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12901100/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12901100/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12901100/full.md

---
Source: https://tomesphere.com/paper/PMC12901100